Search Results 741-750 of 13608 for 📏加🍌line:sammibaby🍌了解力曼直銷🐫很瘦平胸怎麼豐胸🍛產後營養瘦身🎗新竹市腹肌贴有用吗🏷新兴区win7瘦身🛩️暴走多久才有減肥效果🐫kitty强力瘦身操2😘力量直銷
The purpose of this study is to collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved ...
... Line Therapy NCT ID: NCT02649387 POC ID: CLS-20170202; Title: Exploring the Effectiveness of a Flipped Classroom Approach in Anatomy Exploring the ...
Title: A Phase II, Open Label Prospective Single Center Drug Study Evaluating the Safety and Efficacy of ()-Epicatechin in Subjects with Friedreich's Ataxia
Title: A Single-Arm, Multicenter, Open-Label, Phase II Study of Gemcitabine-Cisplatin Chemotherapy plus Necitumumab (IMC-11F8) in the First-Line Treatment ...
Title: XL184-315, A Phase 3, Randomized, Open-Label, Controlled Study of ... Line Treatment of Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Rochester, Minn. This is a Phase 2, open-label, single arm study to evaluate the safety and efficacy of niraparib in ovarian cancer patients who have received ...
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of ...
Title: An Open Label, Phase I/IIa, Dose Escalation Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Volasertib in ...
Jacksonville, Fla., Rochester, Minn. This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients ...
Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.